Skip to main content

Indian Journal of Hematology and Blood Transfusion

Ausgabe 3/2023

Inhalt (29 Artikel)

Review Article

Idiopathic Aplastic anemia: Indian Perspective

Tuphan Kanti Dolai, Manisha Jain, Manoranjan Mahapatra

Open Access Original Article

The Circular RNA Circ-ANAPC7 as a Biomarker for the Risk Stratification of Myelodysplastic Syndrome

Fang Zhou, Shuying Zhang, Mei Huo, Ying Zhou, Libo Jiang, Hong Zhou, Ying Qu

Open Access Original Article

High GLI-1 Expression is a Reliable Indicator of Bad Prognosis in Newly Diagnosed Acute Leukemia Patients

Reham S. El Zaiat, Reem Nabil, Khaled A. Khalifa, Aliaa A. El Feshawy

Original Article

Expression Changes of SIRT1 and FOXO3a Significantly Correlate with Oxidative Stress Resistance Genes in AML Patients

Sharareh Mizani, Ali Keshavarz, Nader Vazifeh Shiran, Davood Bashash, Mehdi Allahbakhshian Farsani

ORIGINAL ARTICLE

Splenic Lymphomas: A Tertiary Care Center Experience and Review of Literature

Surabhi Jain, Prashant Ramteke, Ajay Gogia, Trisha Mandal, Mukul Aggarwal, Jasmita Dass, Mehar Chand Sharma, Manoranjan Mahapatra, Raja Parmanik, Sameer Bakhshi, Atul Sharma, Saumyaranjan Mallick

Open Access Original Article

Second Allogeneic Hematopoietic Stem Cell Transplantation for Hemophagocytic Syndrome with Engraftment Failure

Fan Jiang, Zhouyang Liu, Zikuan Guo, Juan Xiao, Nanhai Wu, Shifen Fan, Yan Yue, Jiao Chen, Yuan Sun

Original Article

Profile and Predictors of Infection Following Anti-thymocyte Globulin or Anti-lymphocyte Globulin with Cyclosporine in Aplastic Anemia

Sharon Anbumalar Lionel, Sushil Selvarajan, Anu Korula, Uday Kulkarni, Anup Devasia, Fouzia N. Abubacker, Aby Abraham, Vikram Mathews, Kavitha M. Lakshmi, Biju George

Open Access Original Article

Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia

S. Chandrakala, Manoj Toshniwal, Mitesh Halvawala, Namita Padwal, Neeraj Sidharthan, Pankaj Malhotra, B. Prashantha, Riya Ballikar, Sandip Shah, Shashikant Apte, T. Kasi Viswanathan, Vijay Ramanan, Akhilesh Sharma, Dattatray Pawar, Roshan Pawar, Vinayaka Shahavi

Original Article

Comparison of Point-of-Care PT-INR by Hand-Held Device with Conventional PT-INR Testing in Anti-phospholipid Antibody Syndrome Patients on Oral Anticoagulation

Arvind Ganapati, John Mathew, Bijesh Yadav, Jayakanthan Kabeerdoss, Mahasampath Gowri, Rutvi Gautam Dave, Roy Thankachen, Sukesh C. Nair

COVID-19 Original Article

Assessment of Transfusion Practices Among Doctors During COVID-19 Pandemic Using Questionnaire-Based Survey

Basanta Khatiwada, Rahul Chaurasia, Gopal Kumar Patidar, Hem Chandra Pandey

ORIGINAL ARTICLE

Evaluation of a New Method of Leukocyte Extractions from the Leukoreduction Filter

Zahra Abbasi Malati, Ali Akbar Pourfathollah, Rasul Dabbaghi, Sahar Balagholi, Mohammad Reza Javan

Short Communication

Bendamustine-Rituximab in Young CLL: Relevance in the Era of Small Molecule Inhibitors

Sukrita Bhattacharjee, Shouriyo Ghosh, Maitreyee Bhattacharyya

Short Communication

Clinico-Hematological Profile in Hemoglobin SE Disease: A Case Series from a Tertiary Care Centre

Tista Basu, Mou Das, Moumita Sengupta, Mamata Guha Mallik Sinha

Short Communication

Utility of Cryohemolysis Test in the Diagnosis of Hereditary Spherocytosis

Venkatesh Dhanasekaran, Sukesh Chandran Nair, Tulasi Geevar, Surendar Singh, Joy John Mammen

Correspondence

Infections Associated Hemophagocytosis-Secondary HLH Mimics in Children!”

Bhavika Rishi, Aroonima Misra, Ravneet Kaur, Varsha Mishra, Sonal Jain, Amitabh Singh

Correspondence

Role of Extracorporeal Membrane Oxygenation (ECMO) and Stem Cell Transplant in the Management of Acute Myeloid Leukaemia with Pulmonary Involvement

Shilpa Prabhu, Richard Dillon, Iara Maria Sequeiros, Caroline Besley FrcPath, David Ian Marks

Correspondence

Immunophenotype, Karyotype and Molecular Findings in a Case of ICF Syndrome

Arun Kumar Arunachalam, Madhavi Maddali, Nancy Beryl Janet, Fouzia N. Aboobacker, Eunice Sindhuvi Edison

IMAGES

Adenopathy in Multiple Myeloma: an Enigma Unravelled by FDG PET

Ashish Mohite, Sayak Choudhury, Nilendu Purandare, Tushar Agrawal, Tanuja Shet, Archi Agrawal, Sneha Shah, Ameya Puranik, Venkatesh Rangarajan

Correction

Correction to: Efects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma

Ayfer Geduk, Berrin Oztas, Baldan Huri Eryılmaz, Esra Terzi Demirsoy, Meral U. Menguc, Serkan Unal, Sinan Mersin, Merve Gokcen Polat, Kemal Aygun, Emel Merve Yenihayat, Hayrunnisa Albayrak, Hasim Atakan Erol, Sibel Balcı, Ozgur Mehtap, Pinar Tarkun, Abdullah Hacihanefioglu

Correction

Correction to: Genetic Spectrum in F13A1 Detected by Next-Generation Sequencing Among North Indian Patients with FXIII Deficiency

Ritika Sharma, Manu Jamwal, Namrata Singh, Prashant Sharma, Deepak Bansal, Amita Trehan, Pankaj Malhotra, Arihant Jain, Jasmina Ahluwalia, Reena Das, Narender Kumar

Open Access Correction

Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia

S. Chandrakala, Manoj Toshniwal, Mitesh Halvawala, Namita Padwal, Neeraj Sidharthan, Pankaj Malhotra, B. Prashantha, Riya Ballikar, Sandip Shah, Shashikant Apte, T. Kasi Viswanathan, Vijay Ramanan, Akhilesh Sharma, Dattatray Pawar, Roshan Pawar, Vinayaka Shahavi

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.